{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:24:32Z","timestamp":1762863872653,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":431,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1002\/rth2.12594","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T07:16:14Z","timestamp":1633763774000},"page":"e12594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rivaroxaban\u2010calibrated chromogenic anti\u2010Xa assay in cirrhosis: Use to rule out disseminated intravascular coagulation"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4388-0349","authenticated-orcid":false,"given":"Fabienne","family":"Lucas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Stecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Pozdnyakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6445-582X","authenticated-orcid":false,"given":"Jean M.","family":"Connors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth M.","family":"Battinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/rth2.12594_bb0010","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/0002-9610(89)90202-X","article-title":"Peritoneovenous shunts palliate malignant ascites","volume":"158","author":"Edney","year":"1989","journal-title":"Am J Surg"},{"key":"10.1002\/rth2.12594_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0011-3840(79)80001-5","article-title":"Ascites: its correction by peritoneovenous shunting","volume":"16","author":"LeVeen","year":"1979","journal-title":"Curr Probl Surg"},{"key":"10.1002\/rth2.12594_bb0020","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1182\/blood-2008-05-160143","article-title":"A dose\u2010ranging study evaluating once\u2010daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein\u2010DVT Dose\u2010Ranging Study","volume":"112","author":"Buller","year":"2008","journal-title":"Blood"},{"key":"10.1002\/rth2.12594_bb0025","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2165\/11595320-000000000-00000","article-title":"Rivaroxaban: population pharmacokinetic analyses in patients treated for acute deep\u2010vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention","volume":"50","author":"Mueck","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"10.1002\/rth2.12594_bb0030","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/jth.15239","article-title":"The concept of rebalanced hemostasis in patients with liver disease: communication from the ISTH SSC working group on hemostatic management of patients with liver disease","volume":"19","author":"Lisman","year":"2021","journal-title":"J Thromb Haemost JTH"},{"key":"10.1002\/rth2.12594_bb0035","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the Study of Liver Diseases","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatol Baltim Md"},{"key":"10.1002\/rth2.12594_bb0040","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/j.gastro.2019.03.070","article-title":"AGA clinical practice update: coagulation in cirrhosis","volume":"157","author":"O\u2019Leary","year":"2019","journal-title":"Gastroenterology"},{"issue":"Suppl 6","key":"10.1002\/rth2.12594_bb0045","first-page":"S1","article-title":"Basic principles of viscoelastic testing","volume":"60","author":"Carll","year":"2020","journal-title":"Transfusion (Paris)"},{"key":"10.1002\/rth2.12594_bb0050","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13397","article-title":"Direct oral anticoagulants and advanced liver disease: a systematic review and meta\u2010analysis","volume":"51","author":"Menichelli","year":"2021","journal-title":"Eur J Clin Invest"},{"issue":"07","key":"10.1002\/rth2.12594_bb0055","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1055\/s-0040-1722192","article-title":"Anticoagulant treatment for splanchnic vein thrombosis in liver cirrhosis: a systematic review and meta\u2010analysis","volume":"121","author":"Valeriani","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1002\/rth2.12594_bb0060","first-page":"104","article-title":"Efficacy and safety of anticoagulation in non\u2010malignant portal vein thrombosis in patients with liver cirrhosis: a systematic review and meta\u2010analysis","volume":"34","author":"Ghazaleh","year":"2021","journal-title":"Ann Gastroenterol"},{"issue":"Suppl 1","key":"10.1002\/rth2.12594_bb0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/ijlh.12992","article-title":"An update on laboratory assessment for direct oral anticoagulants (DOACs)","volume":"41","author":"Gosselin","year":"2019","journal-title":"Int J Lab Hematol"},{"key":"10.1002\/rth2.12594_bb0070","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1182\/blood-2018-04-791541","article-title":"Testing and monitoring direct oral anticoagulants","volume":"132","author":"Connors","year":"2018","journal-title":"Blood"},{"key":"10.1002\/rth2.12594_bb0075","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/rth2.12339","article-title":"An illustrated review of bleeding assessment tools and common coagulation tests","volume":"4","author":"Elbaz","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"year":"2009","series-title":"European Public Assessment Report (EPAR) for Xarelto","key":"10.1002\/rth2.12594_bb0080"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12594","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/rth2.12594","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922014571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922014571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12594","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:21:54Z","timestamp":1762863714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037922014571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S2475037922014571"],"URL":"https:\/\/doi.org\/10.1002\/rth2.12594","relation":{},"ISSN":["2475-0379"],"issn-type":[{"type":"print","value":"2475-0379"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rivaroxaban\u2010calibrated chromogenic anti\u2010Xa assay in cirrhosis: Use to rule out disseminated intravascular coagulation","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/rth2.12594","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 The Authors. Research and Practice in Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}],"article-number":"e12594"}}